<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04632563</url>
  </required_header>
  <id_info>
    <org_study_id>A095310</org_study_id>
    <nct_id>NCT04632563</nct_id>
  </id_info>
  <brief_title>Prevalence of Musculoskeletal Symptoms in the Cambridge NIHR BioResource</brief_title>
  <official_title>Prevalence of Musculoskeletal Symptoms in the Cambridge NIHR BioResource</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cambridge University Hospitals NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Cambridge</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Cambridge University Hospitals NHS Foundation Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Musculoskeletal diseases, such as osteoarthritis, represent a large proportion of the global&#xD;
      burden of disease with hip and knee osteoarthritis alone being the 11th greatest cause of&#xD;
      disease burden.&#xD;
&#xD;
      The purpose of this study is to determine the level of musculoskeletal symptoms in members of&#xD;
      the Cambridge National Institute for Health Research (NIHR) BioResource and see if this is&#xD;
      associated with their possession of genetic markers that have been identified as being&#xD;
      associated with osteoarthritis.&#xD;
&#xD;
      This will allow us to determine the real level of musculoskeletal symptoms in this large&#xD;
      cohort of volunteers and provide basic information that could be used to facilitate further&#xD;
      musculoskeletal research in the NIHR BioResource population.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All active members of the Cambridge NIHR BioResource will be approached.&#xD;
&#xD;
      They will be sent an email outlining the purpose of the study and asking that if they would&#xD;
      like to take part to please complete the online questionnaire which will be linked to in the&#xD;
      email.&#xD;
&#xD;
      For those individuals who agree to participate and complete the questionnaire, the Cambridge&#xD;
      NIHR BioResource will provide the genetic marker information it already holds for specific&#xD;
      markers that are known to be associated with osteoarthritis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2020</start_date>
  <completion_date type="Anticipated">August 2021</completion_date>
  <primary_completion_date type="Anticipated">April 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>MSK Symptom Levels</measure>
    <time_frame>3 months</time_frame>
    <description>Musculoskeletal Symptoms in respondents</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Osteoarthritis genetic marker</measure>
    <time_frame>6 months</time_frame>
    <description>Possession (or not) of specific genetic markers for osteoarthritis (obtained from information already held by the NIHR BioResource)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>MSK Cohort</measure>
    <time_frame>6 months</time_frame>
    <description>Identification of those with particular musculoskeletal injuries and conditions for future studies</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Musculoskeletal Diseases</condition>
  <condition>Musculoskeletal Injury</condition>
  <arm_group>
    <arm_group_label>Member of BioResource</arm_group_label>
    <description>Any BioResource member who consents to take part in the study and completes the study questionnaire.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaire including MSK-HQ (Musculoskeletal Health Questionnaire)</intervention_name>
    <description>A questionnaire regarding musculoskeletal past medical history and current symptoms.</description>
    <arm_group_label>Member of BioResource</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All members of the Cambridge NIHR BioResource&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Member of the NIHR BioResource&#xD;
&#xD;
          -  Willing to consent to participate&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previous self-report of osteoarthritis on joining BioResource&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrew McCaskie</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Cambridge</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Benjamin Davies</last_name>
    <phone>+44 1223 217551</phone>
    <email>bmd35@cam.ac.uk</email>
  </overall_contact>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 11, 2020</study_first_submitted>
  <study_first_submitted_qc>November 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 17, 2020</study_first_posted>
  <last_update_submitted>November 11, 2020</last_update_submitted>
  <last_update_submitted_qc>November 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cambridge University Hospitals NHS Foundation Trust</investigator_affiliation>
    <investigator_full_name>Professor Andrew McCaskie</investigator_full_name>
    <investigator_title>Professor of Orthopaedic Surgery / Head of Department</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Musculoskeletal Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Sharing of participant level data does not fall within the consent or ethical approval of the study.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

